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The elllcscy of propafeoone in preventing induction of 
ventricular tachywrdia was evaluated in 25 consecutive 
p&r& (mean age 62 2 g years) with remote myorardiat 
infarction who underwent programmed electrical stimula- 
tion for ventricular arrhythmia using up to three extra- 
stbxuli after basic drtve at the rirht ventricular anex. In 
nine pottents (Group A), prop&none prevented i&&a 
of sustained vmtrtcular tachycwdia (noninducible in four, 
nanwstntaed (46 sl In five). In the ather 16 gadrnts 
(Group B), sustained wnticulsr tnchycardta was till 
inducible; In II of the 16, the tachycardia configuration was 
unchanged but thecyctetength aassigniAcantly onger (431 
* 99 “erwJs 284 * 44 Ins, p < O.WI). 
Propafmaoe did not rlgnl6cantly a&t either sinus 
cycle length or AH md HV intervals. However, it pro- 
langed QRS duration during sinus rhythm equally in both 
groups of patienls. With vmtrlcular pacing. propafemme 
alp0 pr&~~ged right ventricular effective and functional 
refractmy periods md smfacc QBS duration. There was 
greater lrngthmlng of the paced surface QRS duration 
when drug therapy was inetktive lb example, +35 + 12 
ms in Group A Y~EUE t69 2 23 ms in Group B at z k&c 
drive of404 ms. p C 041). Drug-induced prolongation of a
pxed QXS complex 240 ms had B 94% positive predictive 
value ior drue failure to went induction PI ventricular 
tachycardia. &ugioduced percent prolongation ofventric. 
ular tachycardis cycle kn6th in Grwp B did not corretatc 
sell with percent QRS prolongation. Bather, the best 
correlation WPS with percent prdwgaticm of right ventric. 
ular effective (I = 0.72, p C 0.02) and Lnctional (I = 0.73, 
p < 0.02.1 refractory pe&s at B basic drive af 43, ms. 
These ~bserv~tic-ns rogsert hat exrmke prolongation 
ofeonductlon time tn presumably normal tissue reduces the 
ability of pmpsfenonp to prevent ventricular tscbycardia 
induction. It is spcrulated that rRec& of a drug OR mnduc- 
tion tinre in partiatly refractory abrmrmal tissue forming 
the reentrant circuit may play B rote In detemdrdng the 
tachycsrdta cycle length in the prance of that drug. 
IJ Am CON CurdhI 1990$6:1229Ji) 
Sudden cardiac death resulting from hemodynamically un- 
stable ventricular arrhythmia is a major problem in patients 
discharged from the hospital after myocardial infarction. 
One approach to management in survivors involves the use 
of antianhythmic drugs guided by serial invasive electro- 
physiologic testing. 
Prop&none hydrochloride is d Class IC antiarrhythmic 
agent that causes frequency-dependent sodium channel 
blockade. weak calcium current antagonism and mild beta- 
adrenergic blockade (1.2). It has been found to he effective in 
preventing the induction of sustained ventriculartachycardia 
in this clinical setline: (3-7). However, like other antiarrhyth- 
mic agents, it is no;uniformly successful. Determinants of 
drug ei%xy in preventing ventricular tachycardia presum- 
ably dependent on a reentrant mechanism may involve 
aTccts on conduction or refractoriness. or both. of compo- 
nents of Ihe reentrant circuit. In addition, effects on normal 
tissue may be of importasce in a:loeinp induction of tachy- 
cardia from the right ventricle. 
We therefore retrospectively exammed the effects of 
propafenone on ventricular efractoriness and on conduction 
time in vcxrndar tissue during invasive electraphysiologic 
study in p&ients with sustained ventricular tachycardia. 
Correlation of drug efficacy in preventing induction of ven- 
Table 1. Clinical Data in 2S Rl~ents 
lricular lacbycardis with effect on these variables was men 
attempted. On the basis of these findings. a mechanism of 
drug action is suggested. 
Methods 
Study patients. Twenty-five consecutive patients (22 
men) aged 44 lo 73 years (mean 62 ? 8) with ventricular 
arrhythmias were studied by invasive programmed electrical 
stimulation techniques. Eighteen patients presented with 
documented sustained monomorphic venlriw!ar lachycar- 
dia, three presented with sudden death &wttricular ftbrilla- 
lion1 and four were studied for syocope but had only 
~enlricular premature beats or nonsustained vmtric:ar 
tachycardip recorded by Holler monitoring. Patients pre- 
sented at 4 months lo 20 years after myocardial infarction; in 
four patients (Cases 2.5, 7 and 19) the timing of a previous 
sil.:lt myocardial infarction was unknown. 
Cliniad charaelerislia (Table II. All 25 patients had 
atherosclerotic heart disease and prior myocardial infarc- 
lion: 14 had a left ventricular aneurysm. The electrocardio- 
gran (ECC) at rest yielded clear evidence of prior Q wave 
myocardial infarction in 19 patients, showed B left bundle 
branch block pattern in 3. and only nonspecific ST-T wave 
abnommlities in 3. However, in all patients. segmental wall 
dysfunction was documented by either echocardiography or 
mdionuclide or contrast ventriculogaphy. Significant core- 
nary artery disease (>50% stenosis) was demonstrated in at 
least one vessel in all but two patients: Patient 23 with a 
posteroinierior aneurysm had a 40% lesion at the origin of 
the right coronary artery that was probably recanalized and 
Patient 4 did not undergo coronary angiography. The mean 
ejection fraclion. measured by radionuclide o: contrast 
venlriculography in I8 patients. was 34 + 10% (range 17% to 
47%). 
Elwlmphysiologic sludii. Invasive cardiac ekctrophys- 
iologic studies were performed with the patient in the 
postabsorptive nonsedated slate after written informed con- 
sent WE obtained as previously reported from our labora- 
tory 18). Antiarrbylhmic agents (other than digitalis) were 
discontinued at least five half-lives before the-first study. 
Programmed vemricular stimulation was perfomted with use 
of a digital stimulator (Bloon? A~soc~atcsl with rectangular 
pulses I 5 to 2.0 ms in duration. delivered at twce diastohc 
threshold thrwgb the distal pan of ciectrodes (carhodal 
st!mulalion). Sulfate leads I, IL IIf and V, and intracardiac 
electrograms (filtered at 30 to 500 Hz, were dtqplayed 
simultaneously on a multichannel oscilloscope and recorded 
both on an ink-jet recorder at a paper rpeed of 50 to IO0 
mmls and on a” FM tape recorder for cuhsequent analyn 
Venrricalnr fm’hpcnrdio induction VW attempted in all 
patients at the right ventricular apex with an eight beat drive 
(S,S,) at two basic cycle lengths of &ulation. 600 Ior 5001 
ms and 400 ms. and the introduction of up to two extrastim- 
uii. In addition. a stimulation sequence was wed. consnting 
of eight heats at a short cycle length of 4M) m, and a \mglc 
long r.icle lenah of 600 ms followed by one or two eura- 
stimuli. With use of these methodx sustained vrntncuiar 
tact ycardia was inducible in 22 patients: m 2 patrents (Cases 
7 and 16). three extrastimuli at nn S,S, of 400 ms were 
required to induce ventricular txhycardra and m I pant 
(Case 9). a shorulong sequence NOO/600 ms) with three 
extrastimuli was necessary. 
All parbnn suhrrqaenrf~ received prop&xxr hvlw 
dloride orally at an initial dose of I50 rng three times dnilv. 
This was increased at.48 h intervals to 3M) mg two times 
daily and subsequently to a maximum of 3W mg three time? 
daily as tolerated. After 72 hat the maxim.dly tolerated dose. 
new electrodes were inserted and a repeat study using the 
stimulation protocol already described was performed he- 
tween 2 and 4 h after ingestion of drug In patients in whom 
~entticular tachycardia could not he induced with the pro- 
tocol that had ken successful in the abwtce of drug, 
induction attempts were continued up to a mxximum of three 
extrastimult at two basic cycle ,engths of stimulation to 
assure noninducibility of tachycardia. 
If sustained vrnrrirular rachycardin rmuined nor Inbrc- 
ible. the drug was dejnsd IIS effecti~~~. Correlation between 
efficacy and either I) pmlongation ofright ventricular refnc- 
tory periods. or 2) alteration of conduction time through the 
ventricle was performed retrospectively using data derived 
from electrophysiologic studieg in both the absence and the 
presence of drug. 
Conduction rime through normnl tissue ws nrsseswd I>? 
nww~renwnl of QRS drrrtrrion during sinus nwhm or right 
ventricrdar pecinp. The QRS duration was measured with 
calipers by the principal investigator from the onset to the 
end of the longest QRS complex in leads I. II. 111 and V, at 
a paper speed of 50 mm/s. During right ventr1;e!ar pacing. 
the onget of the QRS complex was identified as the pacing 
spike. At each basic cycle length. the QRS duration of the 
last of eight beats of a drive train was measured and the 
~1s therefore not included i: 8 !he xs!ys of drug etTect on 
paced ORS durntion. Durine sinw rhythm. rhc averaee ORS 
duration of thief successive \eats w& used. Mea&em& 
were .dway\ whin IO ms of the calculated average. Ia 
additwn. QHS durauan was measured during ventricular 
lachycardia of the same configuration before and after drug. 
Three wxc~wc complexes were measured after 10 5 had 
clap\ed from the onset of tachycardia and the average wa 
uwd fnr cawpariaon. Because of the nature of the QRS 
complex in rachycardia loiten wide and without a good 
dctinmos of QKS onret or end). meawrementr \rere more 
vanable Lop to 20 ms from the calculated ~er;lge,. 
Plawra \i,,,iplu\ px druc /,vPl In(1LITlllt-mc”l wcrc dr<wi 
<II riw errd of drc .srbmdorim prororol. Propafenonc and 
5.hydroxypropafenone conccntrationi were determined by 
the technique described by Kannan et al. 19) with high 
petiormancc bquid chromatography. 
Definitions. S, S,, S, nrld S, err fire slim~rbr.s orriJwr.s of 
the last beat of the ventricular drive irain and of the first. 
second and third eurastimuh. respectively. 
V, V,. “, o,rd V, we rile cnrrespnudin,g wz!n’rrrIur 
<&crl-awwzr recorded between de proximal pair of elec- 
trodes on fhe sdme catheter used for stimulatmn. 
Vrmrh uinr effccfiw reframr, period for S, was the 
longest S,S: mterval at which S, failed toevoke VI. This was 
determmed by introducmg a premature (timulils after an 
eight beat drive first late in diarlole and then p:opressively 
decreasing the coupling interval by 10 ms decrementi untd 
S, i&cd IO evoke V,. Reproducibility was verified by 
performme the las two coupling intervals twice. 
~‘~~n~riwiar fiex?ionol rcfincrory period for S, vm the 
$horte*r V,V: interval achieved during the progre<sivc 
ghorteninp of thi: S,S, interval. 
S~rsfniwd wmicnlnr mthycnrdia was defined as a mono- 
morohlc ventricular tachvcardia that lasted 230 s or re- 
quired termination because ofhemodynamic compromise. A 
tachycardia was identified as being of the same configuration 
before and dliring drug therapy by exact carrespondence 
(apan from QRS widening) in a four lead (1. II. III and V,! 
wrface ECG. 
Ststirtical analysis. Data are prewnted as mean values + 
SD. Significant differences between data measured wthout 
and with propalenane were determined by using Student’s 1 
test for paired data. Differences in drug effec between two 
groups of patients were determined by using .dent’s I test 
for unpawd data. Consideration was given to the Bonfcrroni 
correction fdctor for multiple res:s m choosing a critical I 
value corresponding to a p value Gl.05. 
Linear regression analysis was used to determine the 
average if three such measurements was used for data degree of correlation between the percent change in ventric- 
analysis. One patient (Case 7) displayed a QRS configuration ular tachycardia cycle length and the percent change in QRS 
that was different with ventricular pacing in the presence and duration or ventricular refractory pcnods. A p value CO.05 
absence of drug, suggesting a different catheter location. and wa) consldrred stattstically significant. 
ReSUlt.5 
EUeets of propafenone on electrophysiologic characteristics 
(Tahlel). In the total groupofpatients studied. propafenone 
hzd no effect on sinus cycle length. The drug produced 
minimal and insignificant slowing of conduction in the atrio- 
ventricular (AV) node and His-Purkinje system as assessed 
by effect on the AH rnd HV imervals. However, pro- 
p&none significantly prolonged the QRS duration during 
sinus rhythm. 
With venrricular pacing, propafenone significantly pro- 
longed ventricular effective and functional refractory peri- 
ods. Although there was a tendency to greater l ngthening of 
the refractory period at the shorter cycle length of stimula- 
tion. this trend was sot slatisticslly significant. Conduction 
time (ar assessed by surface QRS duration) was also signif- 
icantly lengthened. Furthermore. prolongation of QRS dura- 
tion was significantly greater at a cycle length of400 ms (t59 
i 26 ms) than at 600 ms (t45 + 20 ms) (p < 0.05). An 
example of drug-indoced prolongation of paced surface QRS 
duration is shown in Figtrre I, 
Ventricular tachycardia induction. Susrnincd monomer- 
ph~c wnrricalnr rochycordia wns induced in o/l 2.5 pnrCnrs in 
rhc i:brcnce of drun ~hcrapg. In 3 patients. tachycardia 
induction was achieved with only one extrastimulus and in 
I7 padents with two extrastimuli after a basic drive cycle at 
either 600 or400 ms. In two patients, ventricular tachycardia 
induction necessitated the use of three extrastimuli and in 
three hxtances a short-long sequence l4OQl6N ms) followed 
by two two patients) or three (one patient) extraslimuli was 
required. The mea” cycle length of induced ventricular 
tachycardia was 296 t 56 ms. 
p;olongeb(control284 f 44 ms; &opafenone 43i+ 99 I”;. 
p < O.Cnll) (Fig. IL In these patients. percent prolongation of 
ventricular tachycardia cycle length correlated well with 
percent prolongation of tight ventricular effective and func- 
tional refractory periods and less well with pwcent prolon- 
gation of surface QRS duration. This WBE especially evident 
porwnv IGnxrp A). In Sour of the nine ICanes 5.7, 8 and 91 with ventricular pacing at the faster stimulaiion rate Ir = 
not eve” a single repetitive response was observed despite 
the use of three extrastimuli. In three of these four, the 
coupling intervals inducing ventricular tachywdia could not 
be achieved in the presence of drug because ventricular 
refractoriness had been prolonged beyond these values. In 
three patients. (Cases 2 to 4). a maximum of only 5, I6 and 
8 beats of ventricular tacbycardia, respectively, was in- 
duced. In these patients. coupling intervals similar to thoSe 
that tmder contra1 canditians induced sustained ventricular 
tachycardia “tnv induced nonsustained tachycardia. In the 
first two patients, the cycle length and configuration of this 
nonsustained rhythm were also little changed from control 
ft30 and 0 ms. resoectivelv). In Patient 4. the axis of a left 
bundle branch bloik tachyardia was changed from left to 
normal axis and the cycle length was prolonged by 80 ms. 
Fin&. in two oatients (Cases I and 6). ventricular tachv- . 
cardia of the same configuration as during control conditions 
was inducible but stopped spontaneously at 29 and 22 s. 
respectively. In both these patients, the coupling intervals 
that induced tachycardia were longer in the presence of drug 
(Case I S,S, 670 versus 495 ms; Case 6 S,S, 570 versus 410 
ms). Ventricular tachycardia cycle length was also markedly 
prolonged by 270 and by 203 ms. respectively. 
Snsruined venrricrdur tuchycerdiu remained inducible in 
the remaininn 16 patients IGroup B). In I I patients, the same 
configuration was observed with and without drug. but the 
wcle length of venlricular tachvcardia WIE shnificantlv 
0.72. p < 0.02 far correlation with percent change m effcc- 
live refractory period. but r = 0.29. p = NS for correlation 
with percent change in QRS duration). A similar good 
correlation between percent change in ventricular tachycar- 
dia cvcle lencth and txrcent orohmpiltion of functional 
refractory p&d was odserved (basic d&e 600 ms: r = 0.7 I. 
p < 0.05: basic drive 400 ms: r = 0.73. p < il.021 (Fig. 21. In 
contrast. Figure 3 shows comparatively lesser and nonrig- 
nilicant correlations between percent prolongatiun oi ven- 
tricular tachycardia cycle length and percent prolongatmn of 
surface QRS duration in sinus rhythm and with ventricular 
pacing, and finally the least correlation lr = 0.081 with 
percent change in QRS duration during ven:ricular tachycer- 
dia of the same configuration. 
In the remaining live patients. vrntricular tachycardis 
with a configuration different from that induced without drug 
ws now observed in the presence ofpmpafenonc. Further- 
more, the cycle length of this new tachycardla ranged frum 
140 ms shorter (Case 15) to 2G4 ms longer (Cax 20) than lhar 
of the tachycardia observed in Ihc abrrnce of drug. 
In penera/. vrnrriraluv ~achycordiu ind~~io,t irt Gmrrp B 
QRS duration during drug therapy compared with IS of 16 
patients in Group 8. Thus, paced QRS prolongation HO ms 
had a sensitivity of 94%. a specificity of 83% and a positive 
predictive value of 94% for drug failure in preventing the 
induction of ventricular tachycardia. 
Ventricular effective and functional refractory pctiuds 
were prolonged by drug therapy regardless of efficacy 
against preventing induction of sustained ventricular tachy- 
cardia. Although this pralongation tended to be greater when 
tachycardia remained inducible (Gmup B), this diffcrencs 
was not statistically significant. However, pmlongation of 
ventricular tachycardia cycle length by the presence ofdtug 
was significantly correlated with prolongation of tight ven- 
tricular refractory period. 
phy&& study in 5 patients fmm Group A and 1 I patients 
from Group B. The timing of blued sampling with respect to 
prior drug dose was not different in the two groups. Akhough 
Pmpafemme da@ and pl@ttta levels i-T&k 4). Pro- 
pafenone was administered at “mean daily dose of798 z 172 
mg in the entire group of study patients and the average dose 
administered in Group A was the same as in Gmup 8. 
Plasma ievels af pmpafenone and its main metabulite S-hy 
dmxy-propafettotte were measured at the end of the electm- 
Fitlr 3, Plots showing the relation between the percent change in 
Q+ +iGGeil 
ve”tric”lartaEhycardia cycle leugth IYTCL) and the percent change 
in QRS duration during sinus rhythm WU C&h during pacing at a 
,(HuKTMS-ItL100 
basic cycle length KC,., of MlO ,ns ,B, and 403 ms CC, and during 
,C#UHf(pLI-II 
ventncular lachycardia (VT, of the same configuration tDI. 
required Ihe sww nsmber of exrrastimrdi during drug rher- 
(ILJY (1~ without. Eleven. patients required two extrastimuli 
both with and without dig; howeve;. tte coupling intervals 
that resulted in ventricular tachycardia induction were sig- 
nificantly longer (control S,S, 472 2 48 ms versus pro- 
pafenone S,S, 533 ? 50 ms. p < 0.02). In four patients, only 
one extrastimulus was sufficient whereas in three patients 
(Cases 12,24 and 25) two extrastimuli and in one (Case 17) 
three extrastimuli had been necessary without drug. In only 
one patient (Case II) were three extrastimuli required corn- 
pared with two during the cuntrul study. 
plasma levels tended lo be lower when drug therapy was not 
effective, this difference was not statistically signiticant. 
Plasma levels of pmpafenone or total pmpufenone and 
5.hydroxypropafenone were nut found to correlate with 
either percent change in ventricular tachycardia cycle length 
(r = 0.30 and 0.34. respectively) or percent change in 
ventricular effective refractory period (r = OX@ and 0.08, 
respectively) during therapy. 
Diiussion 
E&t uf pmpafenonc on inducibiliIy uf ventrbxbu tachy- 
cardiu. Previous studies U-7-7) of the effectiveness of pm 
pafenone in preventing induction of ventticular tachycardia 
have observed prolongation of right ventricular refractori- 
ness (with pacing) or QRS duration (in sinus rhythm). but 
have not attempted a correlation with drug etlicacy. We 
observed that drug efficacy was inversely correlated with 
prolongation of paced QRS duration. This elTect was mure 
evident at the faster stimulation frequency (cycle length 400 
ms) and prolongatian of paced QRS duration by Ml ms 
proved to be an excellent predictor of drug failure. 
Differential effects of propafenone related tu afficscy in 
preventing induction uf ventricular tachycardia (Table 3). 
Propafenone bad the same effect on ventricular conduction 
(QRS duration) during sinus rhythm whether or not the drug 
was effective in preventing induction of ventricular lachy- 
cardia (Fig. 4). With ventricular pacing. significantly grater 
lengthening ofQRS duration was observed in Group B than 
in Group A. The greater prolongation of QRS duration in 
Group B versus Group A during drug therapy was not 
related to any difference in baseline QRS duration in these 
tw” groups (p > @.20 at bath 600 and 400 ms basic drive). 
At a ventricular pacing cycle length of 400 ms. only I of 
6 patients in Group A demonstrated NO ms prolongation of 
We have observed in eleclrophysiologic studies of Class 
IA antiarrhythmic drug e0icacy that prolongation of ventric- 
ular effective refractory period at the induction site can play 
a rule in preventing induction of ventricular tachycardia 
(unpublished observations). This is clearly not the case for 
the Class IC drug pmpafenone. Indeed, right ventricular 
effective and hnctional refractory periods tended to prolong 
mure when the drug was ineffective. Despite these effects, 
ventricular tachycardia remained inducible at coupling inter- 
vals exceeding those previously necessary for induction. 
This finding suggests that conduction characteristics of these 
later premature responses were sufficiently affected by the 
drug to now also result in unidirectional block and reentry. 
Greater change in paced QRS duration may grossly reflect 
this detrimental etTect of drug on characteristics of tachycar- 
dia induction. Alternatively. propafenone may have affected 
the reentfant circuit in such B manner that unidirectional 
block now occurred even when impulses arrived at long 
coupling intervals. 
Elk& of pmpafenone an ventricular tachycardia cycle 
length. Prolongation of ventr~ular tachycardia cycle length 
by drug in those cases where it was still inducible WBF not 
well correlated with prolongation of paced QRS duration. 
Indeed. the correlation became wrsr as pacmg cycle length 
was decreased from 600 to 400 ms. In fact. when QRS 
W~ure 4. Bar chart showing rhe prolongarion olQRS duration by 
prapafenoneduringlinus rhythmanddurineright ventricular pacing 
at a basic eyclc length of MO and 4w ms in 9 patients in whom the 
drug prcvemed wrtained ventricular tachycardia induction (Group 
Al and 16 pauenrr in whom it was inekrli s Group B). ‘p 4 0.05, 
Ggnificant GRerence between Groups A and B. 
Table 4, Propfe”o”c Doragc and Plasma Levels length by propafenone may occur by means of an etTect on __~____. 
Talal Croup A Group B conduction through partially refractory tissue in the circuit. 
Fmplenone &ale Irn&U,dl)I I” = 251 tn = 9, I” = 16, 
If this is the case. the class IC agent pmpafenone alTecta 
798 * 17: 767 f ?OS 816 i ISS ventricular tachycardia by a mechanism that is clearly 
Plarma ,ew!q ,l‘#imll ,n = If,, /n = I, ,n= III 
different from that of the class IA drug procainamide. 
Pmparenone ,6? 1.2 ?.3 f 1.” 1.3 e II Spfalation on tbe me&i&m of action of prop&none in 
5-hyddrorypropare”ane 0.20 f 0.11 O.?Y f 0.17 “.I7 f ” II prwenting induclion of sttstalmd ventrkulu tnehycwdia. 
Total 1.8 f I.? 2.6 f 1.2 1.5 r 1.1 When tested by invasive programmed stimulation, an aofi- 
- 
“abet enprcricd as rnca” “.,“a f sn. 
arrhythmic drug may be e6ective in preventing induction of 
sustained ventricular tachycardia by one or bolh of two 
methods. Electrophysiologic variables within the reentrant 
circuit itself may be so altered that despite successful 
duration during tacbycardia of the same configuration was initiation of ventricular tachycardia. it cannot b? maintained. 
compared before aad during drug administration. no corre- This is clearly suggested by the response of our Patients 2,3 
lation was seen. This finding contrasts with the results of and 4. in whom induction characteristics were unchanged 
Marchlinski et al. (101. who repotted on the effects of but the induced tachycardia became unsustainable beyond a 
intravenous prosainamide at baseline study. These investi- few beats. The fact that the cycle length of the induced 
gators found a close correlation between percent prolonga- tachycardia was only slightly altered by the drug suggests 
tion of ventricular tachycardia cycle length and percent that in there cases. an effect on refractoriness of ilo element 
change in QRS duration at a pacing rate that approximated within the circuit or at its exit point was critical in the drug 
the ventricular tachycardia cycle length. Although we did effect against ventricular tachvcardia. 
oat pat: the ventric&r apex at acycl;lengtb approximating 
the tachycardia cycle length. the results we obtained in 
analyzing prolongation of QRS duration during tachycardia 
of the same configuration (that is. origin of depolarization of 
the ventricles and path of propagation unchanged) are 
clearly in contrast with the reported effects of procainamide 
(IO). Our observations suggest rather that the effects of 
propafenone on conduction time through the ventricle do not 
parallel its effects on determinants ofcirculation time within 
the reentrant circuit itself. This is possible because the 
abnormal tissue implicated in the reentrant circuit may react 
differently to prop&none than doer the presumably normal 
!issu: Involved in generating the surface QRS complex. 
We observed a much closer rorrelurion between prolon- 
gation of \w~:ricnlor rocl,ycardio CA length and prolun- 
garion of righr wnrriclrlor refruclo~ period. Such a differ- 
ence between the reported effects of pmcainamide (IO) and 
those we report for propafenone could possibly be inter. 
preted as follows. Recent studies 111.12) of the resettine 
&ponse phenomenon of human ventricular tachycardia 
support the hypothesis that sustained ventricular tachycar- 
dia induced by programntcd electrical stimulation is usually 
based on reentry incorporating an excitable gap. Similarly. 
studie< (131 of this phenomenon in the presence of procain- 
amide. suggest that prolongation of ventricular tachycardi.i 
cycle length by this class IA agent occurs by a slowing of 
conduction in fully repolarized tissue. This is consistent with 
the excellent correlation (101 between proloneation of ven- 
Altei&tely. an antiarrhyth&ic drug may a&t induction 
such that none ofthe coupling intervals attempted is capable 
of producing the conditions necessary for unidirectional 
conduction block and subsequent reentry. This may have 
been the case for our Patients 5.7. Band% in whom noteven 
a single repetitive heat was observed. 
Clearly. cerroin &cts of propafeeaone are counterpro- 
Lcriw to on effecrive onriarrhyhmic mechanism. First, 
excessive depression of conduction in presumably normal 
tissue may act to allow extrastimuli to succeed in arrhythmia 
induction. Even if drug prolongs the refractoriness of the 
reentry circuit tissue. these slowly conducted premature 
impulses may arrive at art appropriate moment to result in 
unidirectional block and reentry. Second, prolongation ot 
conduction time within the reentrant circtut may enhance its 
viability if a drug has a lesser effect on the effective refrac- 
tory period of its components. 
Limit&w of the study. This is a retrospective study 
designed to analyze drug effects specifically on measures of 
conduction time and refactoriness as derived from clinical 
invasive electrophysiologic studiesand to relate theseeffects 
lo drug efficacy in preventing the induction of sustained 
ventricular tachycardia by programmed ventricular stimttla- 
lion. The stiltistical analysis of results measured (and re- 
ported1 thus is limited by the design of the study. Neverthe- 
less. allowing for the appropriate correction (Bonferroni 
inequality formula) for significance at the 0.05 level for 
multiok r tests. observations relatine drue efficacv inverselv 
tricular tacbycardia cycle length and p~olon&on of paced 
. I , 
to effect on surface QRS duration &nain statistically valid. 
surface QRS duration lan &cl on fullv rcoolarized normal Because measures of ORS duration durine rieht ventric- 
lissue). In contrast. the correlation.oh;erved for pro- 
_ _ 
ulilr pacing and measures of ventricular refractory periods 
pafenone with prolongation of ventricular refractory period were compared between control and drug studies performed 
sugge%s that prolongation of ventricular tachycardia cycle on dikrent days, it is possible that catheter location was not 

